8. Gluconeogenesis & Glycogen Metabolism

The pathways that maintain blood glucose homeostasis: gluconeogenesis synthesizes glucose de novo in the liver, while glycogen metabolism provides rapid glucose mobilization and storage through an elegantly regulated phosphorylation cascade.

Derivation 1: Gluconeogenesis Bypass Reactions

Gluconeogenesis is not simply the reversal of glycolysis. Three glycolytic reactions are thermodynamically irreversible under cellular conditions ($\Delta G \ll 0$), so gluconeogenesis employs four bypass reactions catalyzed by different enzymes. The pathway occurs primarily in the liver and, to a lesser extent, the kidney cortex.

Bypass 1: Pyruvate to Phosphoenolpyruvate (PEP)

The pyruvate kinase step ($\Delta G = -16.7\;\text{kJ/mol}$) is bypassed by two reactions:

Step 1a: Pyruvate Carboxylase (Mitochondrial)

$$\text{Pyruvate} + \text{CO}_2 + \text{ATP} + \text{H}_2\text{O} \xrightarrow{\text{PC}} \text{OAA} + \text{ADP} + \text{P}_i$$

$\Delta G°' = -2.1\;\text{kJ/mol}$ | Requires biotin | Activated by acetyl-CoA

Step 1b: PEP Carboxykinase (PEPCK, Cytosolic)

$$\text{OAA} + \text{GTP} \xrightarrow{\text{PEPCK}} \text{PEP} + \text{CO}_2 + \text{GDP}$$

$\Delta G°' = +0.2\;\text{kJ/mol}$ | Note: OAA must be transported from mitochondria as malate

The net reaction for this bypass (per pyruvate):

$$\text{Pyruvate} + \text{ATP} + \text{GTP} + \text{CO}_2 + \text{H}_2\text{O} \rightarrow \text{PEP} + \text{ADP} + \text{GDP} + \text{P}_i + \text{CO}_2$$

Cost: 1 ATP + 1 GTP = 2 high-energy phosphate bonds per pyruvate. The CO$_2$ added in step 1a is removed in step 1b, so there is no net carbon change.

Bypass 2: Fructose-1,6-Bisphosphatase (FBPase-1)

The PFK-1 reaction ($\Delta G = -22.2\;\text{kJ/mol}$) is bypassed by simple hydrolysis:

$$\text{Fructose-1,6-bisP} + \text{H}_2\text{O} \xrightarrow{\text{FBPase-1}} \text{Fructose-6-P} + \text{P}_i$$

$\Delta G°' = -16.3\;\text{kJ/mol}$ | Inhibited by F2,6BP and AMP | Activated by citrate and ATP

Note that this is reciprocally regulated with PFK-1: F2,6BP activates PFK-1 and inhibits FBPase-1, preventing a futile cycle.

Bypass 3: Glucose-6-Phosphatase (G6Pase)

The hexokinase reaction ($\Delta G = -33.4\;\text{kJ/mol}$) is bypassed by hydrolysis in the ER lumen:

$$\text{Glucose-6-P} + \text{H}_2\text{O} \xrightarrow{\text{G6Pase}} \text{Glucose} + \text{P}_i$$

$\Delta G°' = -13.8\;\text{kJ/mol}$ | Found only in liver and kidney (not in muscle or brain)

The absence of G6Pase in muscle means that muscle glycogen cannot directly contribute to blood glucose — a key difference in tissue-specific metabolism.

Total Energy Cost of Gluconeogenesis

To synthesize one glucose from two pyruvate molecules, the costs at each bypass (per glucose) are:

Pyruvate carboxylase ($\times 2$): 2 ATP
PEPCK ($\times 2$): 2 GTP
Reverse of PGK step ($\times 2$): 2 ATP (plus 2 NADH consumed at GAPDH reversal)

Total: 4 ATP + 2 GTP + 2 NADH = 6 ATP equivalents per glucose

Compare this to glycolysis, which yields only 2 ATP per glucose. The additional 4 ATP equivalents ($6 - 2 = 4$) make gluconeogenesis thermodynamically irreversible in the opposite direction:

$$\Delta G_{\text{gluconeogenesis}} = +74\;\text{kJ/mol (glycolysis)} - \text{additional driving force from 4 extra ATP} < 0$$

Derivation 2: The Cori Cycle

The Cori cycle (Carl and Gerty Cori, Nobel Prize 1947) is a metabolic shuttle between muscle and liver that redistributes the metabolic burden during intense exercise.

The Pathway

Muscle: Under anaerobic conditions, glycolysis converts glucose to lactate, generating 2 ATP.
Blood: Lactate is transported from muscle to liver via the bloodstream.
Liver: Gluconeogenesis converts lactate back to glucose, consuming 6 ATP equivalents.
Blood: Glucose is released back into the blood and taken up by muscle.

Energy Accounting

In the muscle:

$$\text{Glucose} \rightarrow 2\;\text{Lactate} + 2\;\text{ATP}$$

In the liver (gluconeogenesis from 2 lactate):

$$2\;\text{Lactate} + 6\;\text{ATP equivalents} \rightarrow \text{Glucose}$$

Note: the first step in liver is lactate dehydrogenase (LDH) converting lactate to pyruvate, generating NADH needed for the GAPDH reversal step:

$$2\;\text{Lactate} + 2\;\text{NAD}^+ \rightarrow 2\;\text{Pyruvate} + 2\;\text{NADH}$$

These 2 NADH are consumed by the GAPDH reversal, so the net ATP cost of gluconeogenesis from lactate is:

$$\text{Cost} = 2\;\text{ATP (PC)} + 2\;\text{GTP (PEPCK)} + 0\;\text{NADH (provided by LDH)} = 4\;\text{ATP equivalents from lactate}$$

Net Cost per Cycle

$$\text{Net cost} = 4\;\text{ATP (liver)} - 2\;\text{ATP (muscle)} = 2\;\text{ATP per cycle}$$

However, when counting the full gluconeogenic cost from pyruvate (6 ATP), the net expenditure is:

$$\text{Net energy deficit} = 6 - 2 = 4\;\text{ATP equivalents}$$

This deficit is paid by the liver through fatty acid oxidation. The Cori cycle effectively shifts the metabolic burden from anaerobic muscle to aerobic liver, allowing sustained high-intensity exercise.

Physiological Significance

Permits anaerobic glycolysis in muscle without lactate accumulation to toxic levels
Recycles carbon (lactate $\rightarrow$ glucose) at the expense of liver ATP
During prolonged exercise, the Cori cycle can account for up to 40% of plasma glucose turnover
Liver uses fatty acids as fuel to power gluconeogenesis (sparing glucose for muscle and brain)

Derivation 3: Glycogen Synthesis and Breakdown

Glycogen is the storage form of glucose in animals — a branched polymer of glucose residues linked by $\alpha(1 \rightarrow 4)$ bonds with $\alpha(1 \rightarrow 6)$ branch points every 8-12 residues. Major stores are in liver (~100 g, for blood glucose homeostasis) and skeletal muscle (~400 g, for local fuel).

Glycogen Breakdown (Glycogenolysis)

Glycogen Phosphorylase

Cleaves $\alpha(1 \rightarrow 4)$ bonds by phosphorolysis (not hydrolysis), producing glucose-1-phosphate:

$$(\text{Glucose})_n + \text{P}_i \xrightarrow{\text{Phosphorylase}} (\text{Glucose})_{n-1} + \text{Glucose-1-P}$$

Uses pyridoxal phosphate (PLP, vitamin B$_6$) as coenzyme. Acts only on terminal $\alpha(1 \rightarrow 4)$ bonds, stopping 4 residues from a branch point.

Debranching Enzyme

Has two activities: (1) transferase moves a trisaccharide from branch to adjacent chain, (2) $\alpha(1 \rightarrow 6)$ glucosidase hydrolyzes the single remaining glucose at the branch point, releasing free glucose.

Phosphoglucomutase

$$\text{Glucose-1-P} \xrightleftharpoons{\text{PGM}} \text{Glucose-6-P}$$

G6P then enters glycolysis (muscle) or is dephosphorylated to free glucose (liver).

The advantage of phosphorolysis over hydrolysis: glucose-1-phosphate is already phosphorylated, saving one ATP compared to free glucose entry into glycolysis. Glycogen breakdown yields 3 ATP per glucose unit in anaerobic glycolysis (vs. 2 for free glucose).

Glycogen Synthesis (Glycogenesis)

UDP-Glucose Pyrophosphorylase

$$\text{Glucose-1-P} + \text{UTP} \rightarrow \text{UDP-Glucose} + \text{PP}_i$$

PP$_i$ is immediately hydrolyzed by pyrophosphatase ($\Delta G°' = -33.5\;\text{kJ/mol}$), making this step irreversible.

Glycogen Synthase

$$\text{UDP-Glucose} + (\text{Glucose})_n \xrightarrow{\text{Glycogen Synthase}} (\text{Glucose})_{n+1} + \text{UDP}$$

Adds glucose to the non-reducing end of an existing glycogen chain. Requires a primer (glycogenin protein provides initial ~8 glucose units).

Branching Enzyme

Transfers a 7-residue block from the end of a chain to create an $\alpha(1 \rightarrow 6)$ branch point. Increases the number of non-reducing ends, allowing faster synthesis and degradation.

The Phosphorylation Cascade

Glycogen metabolism is regulated by a remarkable enzyme cascade that amplifies the hormonal signal by orders of magnitude:

Epinephrine/Glucagon binds to G-protein-coupled receptor
G$_s$ protein activates adenylyl cyclase
Adenylyl cyclase produces cAMP from ATP
cAMP activates protein kinase A (PKA) by binding regulatory subunits
PKA phosphorylates phosphorylase kinase (activating it)
Phosphorylase kinase phosphorylates glycogen phosphorylase b $\rightarrow$ a (activating it)
Glycogen phosphorylase a cleaves glycogen, releasing glucose-1-P

Simultaneously, PKA phosphorylates glycogen synthase, inactivating it. This ensures that glycogen breakdown and synthesis do not occur simultaneously (preventing a futile cycle).

Amplification Factor

Each enzyme in the cascade activates many molecules of the next enzyme, providing enormous signal amplification:

$$\text{Amplification} = \prod_{i=1}^{n} k_i = k_1 \times k_2 \times k_3 \times \cdots \approx 10^5$$

A single molecule of epinephrine can ultimately trigger the release of approximately $10^5$ glucose molecules from glycogen within seconds.

Derivation 4: Blood Glucose Regulation

Blood glucose is maintained within a narrow range (4-6 mM or 70-110 mg/dL in the fasting state) by the opposing actions of insulin (lowers glucose) and glucagon (raises glucose).

Insulin Signaling (Fed State)

After a meal, rising blood glucose stimulates pancreatic $\beta$-cells to secrete insulin:

Insulin Effects

Liver: Activates glucokinase expression, glycogen synthase (via PP1 activation, GSK-3 inhibition), and PFK-2 kinase activity (increasing [F2,6BP]) $\rightarrow$ glycolysis ON, gluconeogenesis OFF
Muscle: Stimulates GLUT4 translocation to membrane, increasing glucose uptake. Activates glycogen synthase and hexokinase II.
Adipose tissue: Promotes GLUT4 translocation, activates lipogenesis (acetyl-CoA carboxylase), inhibits lipolysis (hormone-sensitive lipase)

The insulin signaling pathway:

$$\text{Insulin} \rightarrow \text{IR (receptor)} \rightarrow \text{IRS-1} \rightarrow \text{PI3K} \rightarrow \text{PIP}_3 \rightarrow \text{PDK1} \rightarrow \text{Akt/PKB}$$

Akt phosphorylates and inhibits GSK-3, relieving the inhibitory phosphorylation of glycogen synthase. Akt also activates PP1, which dephosphorylates phosphorylase a $\rightarrow$ b (inactive), further shutting down glycogenolysis.

Glucagon Signaling (Fasted State)

Between meals, falling blood glucose stimulates pancreatic $\alpha$-cells to secrete glucagon:

Glucagon Effects (primarily on liver)

Glycogenolysis ON: cAMP $\rightarrow$ PKA $\rightarrow$ phosphorylase kinase $\rightarrow$ phosphorylase a (active)
Glycogen synthesis OFF: PKA phosphorylates glycogen synthase (inactive)
Gluconeogenesis ON: PKA phosphorylates PFK-2/FBPase-2, activating FBPase-2 and reducing [F2,6BP] $\rightarrow$ PFK-1 inhibited, FBPase-1 activated
Glycolysis OFF: Pyruvate kinase phosphorylated by PKA (less active)
PEPCK and G6Pase: Gene transcription induced by glucagon via CREB

The Insulin/Glucagon Ratio

The metabolic state of the liver is determined by the insulin/glucagon ratio:

$$\text{High}\;\frac{[\text{Insulin}]}{[\text{Glucagon}]}:\;\text{Fed state} \rightarrow \text{glycolysis, glycogen synthesis, lipogenesis}$$

$$\text{Low}\;\frac{[\text{Insulin}]}{[\text{Glucagon}]}:\;\text{Fasted state} \rightarrow \text{gluconeogenesis, glycogenolysis, fatty acid oxidation}$$

Glucose Sensing by the Liver

The liver uses glucokinase (hexokinase IV) as a glucose sensor. Unlike hexokinase I-III:

High $K_m$ ($\approx 10\;\text{mM}$): activity responds to glucose concentrations in the physiological range (5-15 mM)
Not inhibited by G6P: allows continued glucose phosphorylation even when [G6P] is high
Sigmoidal kinetics ($n_H \approx 1.5$): provides a sensitive response to glucose changes around $K_{0.5}$

$$v = V_{\max}\frac{[\text{Glucose}]^{n_H}}{K_{0.5}^{n_H} + [\text{Glucose}]^{n_H}} \quad\text{where}\;K_{0.5} \approx 10\;\text{mM},\;n_H \approx 1.5$$

This means glucokinase is ~50% active at the normal blood glucose concentration, allowing it to respond proportionally to both increases and decreases in glucose.

Reciprocal Regulation: Preventing Futile Cycles

Since glycolysis and gluconeogenesis share seven enzymes (the reversible near-equilibrium steps), they must be reciprocally regulated at the three bypass points. If both pathways ran simultaneously, the net result would be a futile cycle that wastes ATP:

$$\text{ATP} + \text{H}_2\text{O} \rightarrow \text{ADP} + \text{P}_i + \text{heat}\quad(\text{net result of futile cycling})$$

The PFK-1 / FBPase-1 Substrate Cycle

The most important regulatory point is the PFK-1 / FBPase-1 pair. Fructose-2,6-bisphosphate (F2,6BP) is the master regulator that simultaneously:

Activates PFK-1 (decreases $K_{0.5}$ for F6P by ~100-fold)
Inhibits FBPase-1 (increases $K_m$ for F1,6BP)

The bifunctional enzyme PFK-2/FBPase-2 controls [F2,6BP]. Its activity is determined by phosphorylation state:

$$\text{Glucagon} \rightarrow \text{cAMP} \rightarrow \text{PKA} \rightarrow \text{PFK-2/FBPase-2 phosphorylated}$$

$$\text{Phosphorylated form: FBPase-2 active, PFK-2 inactive} \rightarrow [\text{F2,6BP}] \downarrow$$

$$\text{Insulin} \rightarrow \text{PP1} \rightarrow \text{PFK-2/FBPase-2 dephosphorylated}$$

$$\text{Dephosphorylated form: PFK-2 active, FBPase-2 inactive} \rightarrow [\text{F2,6BP}] \uparrow$$

Quantitative Analysis of Reciprocal Regulation

The net flux through the PFK-1/FBPase-1 step is the difference between the forward and reverse rates:

$$J_{\text{net}} = v_{\text{PFK-1}} - v_{\text{FBPase-1}}$$

In the fed state (high [F2,6BP]):

$$v_{\text{PFK-1}} \gg v_{\text{FBPase-1}} \quad \Rightarrow \quad J_{\text{net}} > 0 \quad (\text{glycolysis})$$

In the fasted state (low [F2,6BP]):

$$v_{\text{FBPase-1}} \gg v_{\text{PFK-1}} \quad \Rightarrow \quad J_{\text{net}} < 0 \quad (\text{gluconeogenesis})$$

In practice, some futile cycling does occur (estimated at 5-10% of the forward flux), which may serve as a thermogenic mechanism contributing to basal metabolic rate, and provides a mechanism for rapid switching between glycolysis and gluconeogenesis.

Transcriptional Regulation (Long-term)

Beyond allosteric and covalent regulation (seconds to minutes), transcriptional control adjusts enzyme quantities over hours to days:

Glucagon/cortisol (fasted): Induces PEPCK, G6Pase, pyruvate carboxylase gene expression via CREB and glucocorticoid receptor
Insulin (fed): Represses PEPCK and G6Pase transcription; induces glucokinase, PFK-1, and pyruvate kinase (L-type) expression via SREBP-1c and ChREBP
FOXO1: Transcription factor activated in fasting; promotes gluconeogenic gene expression. Insulin $\rightarrow$ Akt phosphorylates FOXO1, excluding it from the nucleus

Glycogen Storage Diseases and Clinical Applications

Genetic defects in glycogen metabolism enzymes cause a group of inherited metabolic disorders known as glycogen storage diseases (GSDs).

Type I: von Gierke Disease (G6Pase Deficiency)

Most common GSD. Liver cannot release free glucose (G6P accumulates). Symptoms: severe fasting hypoglycemia, massive hepatomegaly, lactic acidosis, hyperuricemia, hyperlipidemia.

Treatment: frequent feeding with cornstarch (slow glucose release), avoid fasting.

Type II: Pompe Disease (Acid Maltase Deficiency)

Deficiency of lysosomal $\alpha$-1,4-glucosidase. Glycogen accumulates in lysosomes, especially in cardiac and skeletal muscle. Infantile form is fatal without treatment.

Treatment: enzyme replacement therapy (recombinant acid $\alpha$-glucosidase).

Type III: Cori Disease (Debranching Enzyme Deficiency)

Cannot degrade glycogen past branch points. Abnormally structured glycogen (limit dextrin) accumulates. Milder hypoglycemia than Type I because gluconeogenesis is intact.

Type V: McArdle Disease (Muscle Phosphorylase Deficiency)

Cannot break down muscle glycogen. Symptoms: exercise intolerance, painful muscle cramps, myoglobinuria. Blood glucose is normal (liver phosphorylase unaffected).

"Second wind" phenomenon: after initial fatigue, increased fatty acid mobilization allows continued exercise.

Type VI: Hers Disease (Liver Phosphorylase Deficiency)

Milder form: hepatomegaly and mild fasting hypoglycemia. Gluconeogenesis compensates partially.

Diabetes Mellitus and Glucose Homeostasis

Diabetes mellitus represents a failure of blood glucose regulation:

Type 1 Diabetes

Autoimmune destruction of pancreatic $\beta$-cells. No insulin production. Uncontrolled gluconeogenesis and glycogenolysis lead to hyperglycemia. Requires exogenous insulin.

Type 2 Diabetes

Insulin resistance in target tissues. Liver continues gluconeogenesis despite high blood glucose (PEPCK and G6Pase not suppressed). Metformin targets hepatic gluconeogenesis via AMPK activation and mild Complex I inhibition.

The relationship between fasting blood glucose and hepatic glucose production:

$$[\text{Glucose}]_{\text{blood}} = \frac{\text{Hepatic glucose output}}{\text{Glucose disposal rate}}$$

In the fasting state, hepatic glucose output ($\approx 2\;\text{mg/kg/min}$) precisely matches peripheral glucose utilization (primarily by the brain, which consumes $\approx 120\;\text{g/day}$). In diabetes, hepatic glucose output is elevated due to:

Increased gluconeogenesis (PEPCK and G6Pase upregulated)
Increased glycogenolysis (glucagon signaling unopposed)
Decreased glycogen synthesis (glycogen synthase not activated by insulin)

Alcohol and Gluconeogenesis

Ethanol metabolism in the liver produces excess NADH via alcohol dehydrogenase and aldehyde dehydrogenase:

$$\text{Ethanol} \xrightarrow{\text{ADH}} \text{Acetaldehyde} \xrightarrow{\text{ALDH}} \text{Acetate}$$

Each step produces NADH, increasing the [NADH]/[NAD$^+$] ratio. This inhibits gluconeogenesis by:

Shifting the lactate DH equilibrium toward lactate (pyruvate unavailable for gluconeogenesis)
Shifting the malate DH equilibrium toward malate (OAA unavailable for PEPCK)
Inhibiting the TCA cycle (high NADH inhibits isocitrate DH and $\alpha$-KGDH)

This is why chronic alcohol consumption on an empty stomach can cause hypoglycemia — the liver cannot maintain gluconeogenesis when NAD$^+$ is depleted.

Fuel Selection During Exercise

The fuel sources used by skeletal muscle depend on exercise intensity and duration:

Temporal Sequence of Fuel Utilization

0-10 seconds: ATP and creatine phosphate stores (immediate energy). Creatine kinase: PCr + ADP $\rightarrow$ Cr + ATP
10 sec - 2 min: Anaerobic glycolysis from muscle glycogen. Rate: very high, but limited by lactate accumulation.
2-30 min: Aerobic glycolysis of muscle glycogen and blood glucose. Cori cycle begins operating.
30 min - 2 hr: Increasing contribution of fatty acid oxidation. Glycogen stores depleting.
$>$2 hr: Fatty acids become dominant fuel. Gluconeogenesis maintains blood glucose for the brain. "Hitting the wall" = glycogen depletion.

The Crossover Concept

As exercise intensity increases, the respiratory exchange ratio (RER) shifts from fat-dominant to carbohydrate-dominant:

$$\text{RER} = \frac{\text{CO}_2\;\text{produced}}{\text{O}_2\;\text{consumed}} = \begin{cases} 0.70 & \text{pure fat oxidation} \\ 0.85 & \text{mixed fuel} \\ 1.00 & \text{pure carbohydrate oxidation} \end{cases}$$

The crossover point (where carbohydrate and fat contribute equally) typically occurs at approximately 65% of VO$_2$max. Above this intensity, the increasing reliance on glycolysis and glycogenolysis is driven by:

Epinephrine-stimulated glycogenolysis (phosphorylase cascade)
Ca$^{2+}$-activated phosphorylase kinase during muscle contraction
AMP-activated glycolysis (allosteric activation of PFK-1)
Insufficient O$_2$ delivery for complete fatty acid oxidation at high workloads

Glycogen Supercompensation

Athletes exploit glycogen metabolism for performance through carbohydrate loading. After glycogen-depleting exercise, a high-carbohydrate diet can increase muscle glycogen stores by 2-3 fold above normal levels (~200 to ~600 mmol glucose units/kg dry weight). The mechanism involves:

Increased GLUT4 translocation (exercise-stimulated, independent of insulin)
Increased glycogen synthase activity (allosteric activation by G6P, dephosphorylation by PP1)
Increased insulin sensitivity post-exercise

Python Simulations

Cori Cycle Energetics

Python

Visualize the ATP balance of the Cori cycle between muscle (glycolysis) and liver (gluconeogenesis).

script.py103 lines

import numpy as np
import matplotlib.pyplot as plt

# Cori Cycle energetics: lactate shuttle between muscle and liver
fig, axes = plt.subplots(1, 2, figsize=(14, 6))

# Panel 1: Energy balance of the Cori Cycle
ax1 = axes[0]
processes = [
    'Muscle:\nGlycolysis',
    'Muscle:\nNet ATP',
    'Liver:\nGluconeogenesis',
    'Liver:\nATP Cost',
    'Net Cori\nCycle Cost'
]
atp_values = [2, 2, 0, -6, -4]
colors = ['#34d399' if v >= 0 else '#f87171' for v in atp_values]

bars = ax1.bar(range(len(processes)), atp_values, color=colors, alpha=0.85,
               edgecolor='white', linewidth=0.5, width=0.6)
ax1.set_xticks(range(len(processes)))
ax1.set_xticklabels(processes, fontsize=9, color='white')
ax1.set_ylabel('ATP Equivalents', fontsize=12, color='white')
ax1.set_title('Cori Cycle: Energy Balance', fontsize=14, color='white', fontweight='bold')
ax1.axhline(y=0, color='white', linewidth=0.5)
ax1.set_facecolor('#0a0a1a')
ax1.tick_params(colors='white')
ax1.grid(True, alpha=0.2, color='#34d399', axis='y')
for spine in ax1.spines.values():
    spine.set_color('#34d399')

# Add value labels
for bar, val in zip(bars, atp_values):
    y_pos = val + 0.15 if val >= 0 else val - 0.3
    ax1.text(bar.get_x() + bar.get_width()/2, y_pos,
             f'{val:+d} ATP', ha='center', va='bottom' if val >= 0 else 'top',
             fontsize=11, color='white', fontweight='bold')

# Panel 2: Gluconeogenesis vs Glycolysis energy comparison
ax2 = axes[1]
pathways = ['Glycolysis\n(Glucose -> 2 Pyr)', 'Gluconeogenesis\n(2 Pyr -> Glucose)']
steps_glyc = {
    'Hexokinase': -1,
    'PFK-1': -1,
    'PGK (x2)': 2,
    'PK (x2)': 2,
    'GAPDH (x2 NADH)': 0,
}
steps_gluco = {
    'Pyruvate Carboxylase (x2)': -2,
    'PEPCK (x2 GTP)': -2,
    'Fructose-1,6-BPase': 0,
    'Glucose-6-Phosphatase': 0,
    'Reversal of PGK (x2)': -2,
    'GAPDH reversal (x2 NADH)': 0,
}

# Bar chart comparing ATP costs
categories = ['Substrate-level\nATP (glycolysis)',
              'ATP cost\n(gluconeogenesis)',
              'Net difference']
values = [2, -6, -4]
bar_colors = ['#34d399', '#f87171', '#fbbf24']

bars2 = ax2.bar(range(len(categories)), values, color=bar_colors, alpha=0.85,
                edgecolor='white', linewidth=0.5, width=0.5)
ax2.set_xticks(range(len(categories)))
ax2.set_xticklabels(categories, fontsize=10, color='white')
ax2.set_ylabel('ATP Equivalents', fontsize=12, color='white')
ax2.set_title('Glycolysis vs Gluconeogenesis ATP', fontsize=14, color='white', fontweight='bold')
ax2.axhline(y=0, color='white', linewidth=0.5)
ax2.set_facecolor('#0a0a1a')
ax2.tick_params(colors='white')
ax2.grid(True, alpha=0.2, color='#34d399', axis='y')
for spine in ax2.spines.values():
    spine.set_color('#34d399')

for bar, val in zip(bars2, values):
    y_pos = val + 0.15 if val >= 0 else val - 0.3
    ax2.text(bar.get_x() + bar.get_width()/2, y_pos,
             f'{val:+d}', ha='center', va='bottom' if val >= 0 else 'top',
             fontsize=12, color='white', fontweight='bold')

fig.patch.set_facecolor('#0a0a1a')
plt.tight_layout()
plt.savefig('output.png', dpi=150, bbox_inches='tight', facecolor='#0a0a1a')
plt.show()

print("=== Cori Cycle Summary ===")
print("MUSCLE (anaerobic):")
print("  Glucose -> 2 Lactate + 2 ATP")
print()
print("LIVER (aerobic):")
print("  2 Lactate -> Glucose")
print("  Cost: 2 ATP (pyruvate carboxylase)")
print("        2 GTP (PEPCK)")
print("        2 NADH (reverse GAPDH)")
print("  Total: 6 ATP equivalents")
print()
print("NET cost per Cori cycle turn: 6 - 2 = 4 ATP equivalents")
print("This cost is paid by the liver using fatty acid oxidation.")

Click Run to execute the Python code

Code will be executed with Python 3 on the server

Glycogen Phosphorylase Cascade Amplification

Python

Explore the signal amplification cascade from epinephrine binding to glycogen mobilization, and the kinetics of phosphorylase activation.

script.py105 lines

import numpy as np
import matplotlib.pyplot as plt

# Glycogen phosphorylase cascade amplification
# Epinephrine -> cAMP -> PKA -> Phosphorylase kinase -> Glycogen phosphorylase

fig, axes = plt.subplots(1, 2, figsize=(14, 6))

# Panel 1: Cascade amplification at each step
ax1 = axes[0]
cascade_steps = [
    'Epinephrine\nbinding',
    'G-protein\nactivation',
    'Adenylyl\ncyclase',
    'cAMP\nproduction',
    'PKA\nactivation',
    'Phosphorylase\nkinase',
    'Glycogen\nphosphorylase',
    'Glucose-1-P\nrelease'
]

# Amplification factors at each level (molecules activated per event)
amplification = [1, 10, 10, 100, 100, 1000, 10000, 100000]

# Use log scale
ax1.barh(range(len(cascade_steps)), np.log10(np.array(amplification) + 1),
         color=['#60a5fa', '#60a5fa', '#a78bfa', '#a78bfa', '#34d399',
                '#34d399', '#fbbf24', '#f87171'],
         alpha=0.85, height=0.6, edgecolor='white', linewidth=0.5)

ax1.set_yticks(range(len(cascade_steps)))
ax1.set_yticklabels(cascade_steps, fontsize=9, color='white')
ax1.set_xlabel('log10(Molecules Activated)', fontsize=11, color='white')
ax1.set_title('Cascade Amplification', fontsize=14, color='white', fontweight='bold')
ax1.set_facecolor('#0a0a1a')
ax1.tick_params(colors='white')
ax1.grid(True, alpha=0.2, color='#34d399', axis='x')
for spine in ax1.spines.values():
    spine.set_color('#34d399')

# Add value annotations
for i, amp in enumerate(amplification):
    ax1.text(np.log10(amp + 1) + 0.1, i, f'{amp:,}x',
             va='center', fontsize=9, color='white', fontweight='bold')

# Panel 2: Time course of phosphorylase activation
ax2 = axes[1]
t = np.linspace(0, 60, 300)  # seconds

# Model: cascade introduces time delays but rapid amplification
# Each step adds a sigmoidal delay
def cascade_response(t, t_half, n):
    """Sigmoidal activation time course."""
    return 1 / (1 + (t_half / (t + 0.01))**n)

# Different hormone concentrations
epi_concs = [0.1, 1.0, 10.0]  # nM
colors_epi = ['#60a5fa', '#34d399', '#fbbf24']

for epi, color in zip(epi_concs, colors_epi):
    # Higher epinephrine -> faster response (lower t_half)
    t_half = 15 / (epi ** 0.3)
    response = cascade_response(t, t_half, 3)
    ax2.plot(t, response * 100, color=color, linewidth=2.5,
             label=f'[Epi] = {epi} nM')

ax2.set_xlabel('Time (seconds)', fontsize=11, color='white')
ax2.set_ylabel('Phosphorylase a (% active)', fontsize=11, color='white')
ax2.set_title('Phosphorylase Activation Kinetics', fontsize=14, color='white', fontweight='bold')
ax2.legend(fontsize=10, facecolor='#1a1a2e', edgecolor='#34d399', labelcolor='white')
ax2.set_facecolor('#0a0a1a')
ax2.tick_params(colors='white')
ax2.grid(True, alpha=0.2, color='#34d399')
for spine in ax2.spines.values():
    spine.set_color('#34d399')

# Add annotations
ax2.axhline(y=50, color='#f87171', linestyle='--', alpha=0.5, linewidth=1)
ax2.text(55, 53, 'Half-max', fontsize=9, color='#f87171')

fig.patch.set_facecolor('#0a0a1a')
plt.tight_layout()
plt.savefig('output.png', dpi=150, bbox_inches='tight', facecolor='#0a0a1a')
plt.show()

print("=== Glycogen Phosphorylase Cascade ===")
print("Signal amplification from 1 epinephrine molecule:")
print()
for step, amp in zip(cascade_steps, amplification):
    clean = step.replace('\n', ' ')
    print(f"  {clean}: ~{amp:,} molecules")
print()
print("Total amplification: ~100,000-fold")
print("A single hormone molecule triggers release of ~100,000 glucose units!")
print()
print("=== Regulation Summary ===")
print("Phosphorylase b (inactive, T-state) <-> Phosphorylase a (active, R-state)")
print("  Activation: phosphorylation by phosphorylase kinase")
print("  Inactivation: dephosphorylation by PP1 (protein phosphatase 1)")
print()
print("Glycogen synthase (active) <-> Glycogen synthase (inactive)")
print("  Inactivation: phosphorylation by GSK-3, PKA")
print("  Activation: dephosphorylation by PP1 (stimulated by insulin)")

Click Run to execute the Python code

Code will be executed with Python 3 on the server

Gluconeogenic Precursors

Any non-carbohydrate compound that can be converted to pyruvate, oxaloacetate, or any TCA cycle intermediate can serve as a gluconeogenic precursor. The major precursors are:

Lactate

The most quantitatively important precursor during exercise and in the fasted state. Produced by anaerobic glycolysis in muscle, erythrocytes, and other tissues. Enters gluconeogenesis via LDH:

$$\text{Lactate} + \text{NAD}^+ \xrightarrow{\text{LDH}} \text{Pyruvate} + \text{NADH} + \text{H}^+$$

Amino Acids

Glucogenic amino acids are those whose carbon skeleton can be converted to pyruvate or TCA cycle intermediates. All amino acids except leucine and lysine (which are purely ketogenic) can contribute to glucose synthesis. Alanine is particularly important:

$$\text{Alanine} + \alpha\text{-KG} \xrightarrow{\text{ALT}} \text{Pyruvate} + \text{Glutamate}$$

The glucose-alanine cycle is analogous to the Cori cycle: muscle transaminates pyruvate to alanine (using amino groups from branched-chain amino acid catabolism), alanine is transported to the liver, and the liver converts it back to pyruvate for gluconeogenesis. The amino group is disposed of via the urea cycle.

Glycerol

Released from triacylglycerol hydrolysis (lipolysis) in adipose tissue. Glycerol enters gluconeogenesis at the level of DHAP:

$$\text{Glycerol} \xrightarrow{\text{glycerol kinase}} \text{Glycerol-3-P} \xrightarrow{\text{G3P DH}} \text{DHAP}$$

During prolonged fasting, glycerol can account for up to 20% of hepatic glucose production. Note that glycerol kinase is expressed primarily in the liver — adipose tissue lacks this enzyme, so glycerol must be transported to the liver.

Propionate (Odd-Chain Fatty Acids)

Odd-chain fatty acids produce propionyl-CoA in the last round of $\beta$-oxidation, which is converted to succinyl-CoA and enters gluconeogenesis. Even-chain fatty acids produce only acetyl-CoA, which cannot be converted to glucose in animals (because acetyl-CoA entering the TCA cycle loses both carbons as CO$_2$ before reaching OAA). This is a fundamental limitation of animal metabolism.

$$\text{Propionyl-CoA} \xrightarrow{\text{PC carboxylase}} \text{D-Methylmalonyl-CoA} \xrightarrow{\text{racemase}} \text{L-Methylmalonyl-CoA} \xrightarrow{\text{mutase (B}_{12}\text{)}} \text{Succinyl-CoA}$$

Quantitative Contributions During Fasting

During a 24-hour fast, the liver produces approximately 180-200 g of glucose. The approximate contributions:

Glycogenolysis: ~75% in first 12 hours, declining to ~10% by 24 hours (glycogen stores deplete)
Gluconeogenesis from lactate: ~25-30% (Cori cycle + brain lactate recycling)
Gluconeogenesis from amino acids: ~25-30% (primarily alanine and glutamine from muscle)
Gluconeogenesis from glycerol: ~10-20% (increases with prolonged fasting as lipolysis accelerates)

By 48-72 hours of fasting, gluconeogenesis accounts for essentially all glucose production. The kidney contributes up to 40% of gluconeogenesis during prolonged starvation, using glutamine as the primary precursor.

AMPK: The Cellular Fuel Gauge

AMP-activated protein kinase (AMPK) is a master regulator of cellular energy homeostasis that integrates signals from glucose metabolism, fatty acid metabolism, and mitochondrial function.

Activation Mechanism

AMPK is activated when the cellular energy charge falls (AMP/ATP ratio increases):

$$\text{Low energy} \rightarrow [\text{AMP}]\uparrow, [\text{ATP}]\downarrow \rightarrow \text{AMP binds AMPK } \gamma\text{ subunit} \rightarrow \text{AMPK activated}$$

AMPK activation involves three mechanisms: (1) allosteric activation by AMP binding (~2-5 fold), (2) promotion of phosphorylation by upstream kinases (LKB1, CaMKK$\beta$), and (3) inhibition of dephosphorylation. Together these can produce >100-fold activation.

Effects on Glucose and Glycogen Metabolism

Stimulates glucose uptake: Promotes GLUT4 translocation (insulin-independent pathway)
Stimulates glycolysis: Phosphorylates and activates PFK-2 in heart (increasing F2,6BP)
Inhibits glycogen synthesis: Phosphorylates glycogen synthase (inactivating it)
Inhibits gluconeogenesis: Phosphorylates and promotes degradation of CRTC2/TORC2, a coactivator of CREB-dependent gluconeogenic gene expression
Stimulates fatty acid oxidation: Phosphorylates and inactivates ACC (acetyl-CoA carboxylase), lowering malonyl-CoA, which relieves CPT-1 inhibition
Inhibits fatty acid synthesis: Via ACC inactivation

AMPK and Metformin

Metformin, the most widely prescribed drug for type 2 diabetes, works partly by activating AMPK. It mildly inhibits mitochondrial Complex I, increasing the AMP/ATP ratio. The resulting AMPK activation:

Suppresses hepatic gluconeogenesis (the primary therapeutic action)
Enhances peripheral glucose uptake
Reduces hepatic lipogenesis
Improves insulin sensitivity

This illustrates how understanding the molecular details of metabolic regulation leads directly to therapeutic strategies for metabolic disease.

Key Takeaways

Gluconeogenesis uses 4 bypass reactions (costing 6 ATP per glucose) to circumvent the 3 irreversible steps of glycolysis.
The Cori cycle shuttles lactate from anaerobic muscle to liver, where it is reconverted to glucose at a net cost of 4 ATP equivalents.
Glycogen phosphorylase cleaves glycogen by phosphorolysis, yielding G1P (saves 1 ATP vs. free glucose).
The epinephrine signaling cascade (GPCR $\rightarrow$ cAMP $\rightarrow$ PKA $\rightarrow$ phosphorylase kinase $\rightarrow$ phosphorylase a) amplifies the signal ~$10^5$-fold.
Insulin promotes glucose storage (glycolysis, glycogenesis); glucagon promotes glucose mobilization (glycogenolysis, gluconeogenesis).
F2,6BP is the key reciprocal regulator: activates PFK-1 (glycolysis) and inhibits FBPase-1 (gluconeogenesis), controlled by the insulin/glucagon ratio.

← Oxidative Phosphorylation Part III: Metabolic Pathways →